Author name: PRNewswire

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in the Shares of Certain Western Asset Management Company, LLC Mutual Fund Classes of Class Action Lawsuit and Upcoming Deadlines

NEW YORK, July 27, 2025 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against Western Asset Management Company, LLC (“WAMCO”), Franklin Resources, Inc., and Stephen Kenneth Leech, II (“Leech”) (together, the “Defendants”), on behalf of investors in the shares of the “Western Asset US Core Bond Fund” mutual fund classes

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in the Shares of Certain Western Asset Management Company, LLC Mutual Fund Classes of Class Action Lawsuit and Upcoming Deadlines Read Post »

Press

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Neogen Corporation – NEOG

NEW YORK, July 27, 2025 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Neogen Corporation (“Neogen” or the “Company”) (NASDAQ: NEOG).  Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.   The investigation concerns whether Neogen and certain of its officers and/or directors have engaged in securities fraud or other

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Neogen Corporation – NEOG Read Post »

Press

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Jasper Therapeutics, Inc. – JSPR

NEW YORK, July 27, 2025 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Jasper Therapeutics, Inc. (“Jasper” or the “Company”) (NASDAQ: JSPR). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.  The investigation concerns whether Jasper and certain of its officers and/or directors have engaged in securities fraud or other unlawful

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Jasper Therapeutics, Inc. – JSPR Read Post »

Press

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Centene Corporation of Class Action Lawsuit and Upcoming Deadlines – CNC

NEW YORK, July 27, 2025 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against Centene Corporation (“Centene” or the “Company”)(NYSE: CNC). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Centene Corporation of Class Action Lawsuit and Upcoming Deadlines – CNC Read Post »

Press

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in RxSight, Inc. of Class Action Lawsuit and Upcoming Deadlines – RXST

NEW YORK, July 27, 2025 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against RxSight, Inc. (“RxSight” or the “Company”)(NASDAQ: RXST). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number,

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in RxSight, Inc. of Class Action Lawsuit and Upcoming Deadlines – RXST Read Post »

Press

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Mereo BioPharma Group plc – MREO

NEW YORK, July 27, 2025 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Mereo BioPharma Group plc (“Mereo” or the “Company”) (NASDAQ: MREO). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980. The investigation concerns whether Mereo and certain of its officers and/or directors have engaged in securities fraud

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Mereo BioPharma Group plc – MREO Read Post »

Press

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of The J.M. Smucker Company – SJM

NEW YORK, July 27, 2025 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of  The J.M. Smucker Company (“Smucker” or the “Company”) (NYSE: SJM). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980. The investigation concerns whether Smucker and certain of its officers and/or directors have engaged in securities fraud

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of The J.M. Smucker Company – SJM Read Post »

Press

Pomerantz Law Firm Announces the Filing of a Class Action Against 3D Systems Corporation and Certain Officers – DDD

NEW YORK, July 27, 2025 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against 3D Systems Corporation (“3D Systems” or the “Company”) (NYSE: DDD) and certain officers. The class action, filed in the United States District Court for the District of Delaware, and docketed under 25-cv-00734, is on behalf of a

Pomerantz Law Firm Announces the Filing of a Class Action Against 3D Systems Corporation and Certain Officers – DDD Read Post »

Press
Scroll to Top